US 12053513
Cancer-specific T-cell receptors
granted A61KA61K2039/5158A61K2039/70
Quick answer
US patent 12053513 (Cancer-specific T-cell receptors) held by University College Cardiff Consultants Limited expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- University College Cardiff Consultants Limited
- Grant date
- Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/5158, A61K2039/70, A61K38/00, A61K38/08